FME:ETR
Fresenius Medical Care AG
39,59 €
arrow_upward
+2,99%(+1,15) 1D
14 қыр., 17:01:43 GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for FME...
Open
39,00 €
High
39,67 €
Low
38,79 €
Mkt. cap
10,64 млрд
Avg. vol.
841,07 м.
Volume
416,96 м.
Dividend
3,76%
Quarterly dividend
0,37 €
Ex-dividend date
2026 ж. 22 мам.
P/E ratio
11,90
52-wk high
47,86 €
52-wk low
34,57 €
EPS
3,33 €
Shares outstanding
268,56 млн
No. of employees
107 м.
Open
39,00 €
High
39,67 €
Low
38,79 €
Mkt. cap
10,64 млрд
Avg. vol.
841,07 м.
Volume
416,96 м.
Dividend
3,76%
Quarterly dividend
0,37 €
Ex-dividend date
2026 ж. 22 мам.
P/E ratio
11,90
52-wk high
47,86 €
52-wk low
34,57 €
EPS
3,33 €
Shares outstanding
268,56 млн
No. of employees
107 м.
News stories
From web sources and news partners
ad-hoc-news.de
·
1 күн бұрын
Fresenius Medical Care stock holds steady as analysts stay cautious
Profile
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease, which requires patients to undergo dialysis 3 times per week for the rest of their lives.
With a global headquarters in Bad Homburg vor der Höhe, Germany, and a North American headquarters in Waltham, Massachusetts, it has a 38% market share of the dialysis market in the United States. It also operates 42 production sites, the largest of which are in the U.S., Germany, and Japan.
The company is 32% owned by Fresenius and, as of 2020, generates around 50% of the group's revenue.
As of 2024, the company was ranked as #612 on the World's Best Employers list published by Forbes. Wikipedia
About Fresenius Medical Care AG
CEOHelen Giza
Employees107 м.
Founded1996
Headquarters-
SectorHealth care provider
Websitefreseniusmedicalcare.com